Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Bertotti

Showing results (71-80 of 99) with videos related to

Pageof 10
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2011
Genetic and expression analysis of MET, MACC1, and HGF in metastatic colorectal cancer: response to met inhibition in patient xenografts and pathologic correlationsFrancesco Galimi, Davide Torti, Francesco Sassi, et al.
Genome Medicine|October 10, 2024
DNA demethylation triggers cell free DNA release in colorectal cancer cellsValeria Pessei, Marco Macagno, Elisa Mariella, et al.
Nature Cell Biology|April 2, 2021
Quantifying single-cell ERK dynamics in colorectal cancer organoids reveals EGFR as an amplifier of oncogenic MAPK pathway signallingBas Ponsioen, Jasmin B Post, Julian R Buissant des Amorie, et al.
Cancer Discovery|May 16, 2012
A molecularly annotated platform of patient-derived xenografts ("xenopatients") identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancerAndrea Bertotti, Giorgia Migliardi, Francesco Galimi, et al.
Nature Communications|August 29, 2024
XENTURION is a population-level multidimensional resource of xenografts and tumoroids from metastatic colorectal cancer patientsSimonetta M Leto, Elena Grassi, Marco Avolio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 15, 2015
MEK plus PI3K/mTORC1/2 Therapeutic Efficacy Is Impacted by TP53 Mutation in Preclinical Models of Colorectal CancerCelina García-García, Martín A Rivas, Yasir H Ibrahim, et al.
Science Translational Medicine|May 21, 2025
Heterogeneity and evolution of DNA mutation rates in microsatellite stable colorectal cancerElena Grassi, Valentina Vurchio, George D Cresswell, et al.
BMC Genomics|February 23, 2022
The EurOPDX Data Portal: an open platform for patient-derived cancer xenograft data sharing and visualizationZdenka Dudová, Nathalie Conte, Jeremy Mason, et al.
Cancers|October 17, 2020
Implementing Systems Modelling and Molecular Imaging to Predict the Efficacy of BCL-2 Inhibition in Colorectal Cancer Patient-Derived Xenograft ModelsAlice C O'Farrell, Monika A Jarzabek, Andreas U Lindner, et al.
Nature|April 12, 2019
Prioritization of cancer therapeutic targets using CRISPR-Cas9 screensFiona M Behan, Francesco Iorio, Gabriele Picco, et al.
Pageof 10

Showing results (71-80 of 99) with videos related to

Sort By:
Pageof 10
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2011
Genetic and expression analysis of MET, MACC1, and HGF in metastatic colorectal cancer: response to met inhibition in patient xenografts and pathologic correlationsFrancesco Galimi, Davide Torti, Francesco Sassi, et al.
Genome Medicine|October 10, 2024
DNA demethylation triggers cell free DNA release in colorectal cancer cellsValeria Pessei, Marco Macagno, Elisa Mariella, et al.
Nature Cell Biology|April 2, 2021
Quantifying single-cell ERK dynamics in colorectal cancer organoids reveals EGFR as an amplifier of oncogenic MAPK pathway signallingBas Ponsioen, Jasmin B Post, Julian R Buissant des Amorie, et al.
Cancer Discovery|May 16, 2012
A molecularly annotated platform of patient-derived xenografts ("xenopatients") identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancerAndrea Bertotti, Giorgia Migliardi, Francesco Galimi, et al.
Nature Communications|August 29, 2024
XENTURION is a population-level multidimensional resource of xenografts and tumoroids from metastatic colorectal cancer patientsSimonetta M Leto, Elena Grassi, Marco Avolio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 15, 2015
MEK plus PI3K/mTORC1/2 Therapeutic Efficacy Is Impacted by TP53 Mutation in Preclinical Models of Colorectal CancerCelina García-García, Martín A Rivas, Yasir H Ibrahim, et al.
Science Translational Medicine|May 21, 2025
Heterogeneity and evolution of DNA mutation rates in microsatellite stable colorectal cancerElena Grassi, Valentina Vurchio, George D Cresswell, et al.
BMC Genomics|February 23, 2022
The EurOPDX Data Portal: an open platform for patient-derived cancer xenograft data sharing and visualizationZdenka Dudová, Nathalie Conte, Jeremy Mason, et al.
Cancers|October 17, 2020
Implementing Systems Modelling and Molecular Imaging to Predict the Efficacy of BCL-2 Inhibition in Colorectal Cancer Patient-Derived Xenograft ModelsAlice C O'Farrell, Monika A Jarzabek, Andreas U Lindner, et al.
Nature|April 12, 2019
Prioritization of cancer therapeutic targets using CRISPR-Cas9 screensFiona M Behan, Francesco Iorio, Gabriele Picco, et al.
Pageof 10